BioSpace News Archive

Business

ANI Pharmaceuticals Reports Second Quarter 2021 Results

ANI Pharmaceuticals, Inc., (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2021.

August 6, 2021
·
21 min read
Braxia Scientific Announces Participation at Canaccord Genuity 2021 Annual Growth Conference August 10-12

Braxia Scientific Corp. is pleased to announce its participation at the upcoming Canaccord Genuity Annual Growth Conference. The conference will be held virtually on August 10-12, 2021.

August 6, 2021
·
4 min read
Pharm Country

Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference

Aquestive Therapeutics, Inc. announced today that the management team will participate in a panel entitled “Got My Mind Set On You - Advancing Novel Epilepsy Targets” at the 12 th Annual Wedbush PacGrow Healthcare Virtual Conference to be held on Wednesday, August 11, 2021 am ET.

August 6, 2021
·
6 min read
Biotech Bay

10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.

August 6, 2021
·
1 min read
Biotech Beach

GT Biopharma to Host Conference Call to Discuss Second Quarter 2021 Results

GT Biopharma, Inc. today announced that the management team will host a conference call to discuss second quarter 2021 financial results and general business updates on August 13, 2021 at 8:30 a.m. EST.

August 6, 2021
·
4 min read
Business

Replimune Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update

hReplimune Group, Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, announced financial results for the fiscal first quarter ended June 30, 2021 and provided a business update.

August 6, 2021
·
14 min read
Lone Star Bio

BioStable Science & Engineering Initiates European Commercialization of the HAART™ 200 Aortic Annuloplasty Device

BioStable Science & Engineering, Inc. announced today that the first commercial implantations of its HAART 200 Aortic Annuloplasty Device were performed on Monday, August 2 nd by Professor Marek Jasinski, Chief of Cardiac Surgery at Wroclaw Medical University of Silesia.

August 6, 2021
·
3 min read
Business

BioTheryX Announces Appointments of Three New Members to its Board of Directors

BioTheryX, Inc. today announced the appointments of Nancy Miller-Rich , John A. Hohneker , M.D., and Diantha Duvall to its Board of Directors.

August 6, 2021
·
4 min read
Deals

iCo Therapeutics Inc. Announces Shareholder Approval of Business Combination with Satellos Bioscience Inc.

The Company expects trading of the shares of the combined company to begin trading on the TSX Venture Exchange as Satellos Bioscience Inc. under the symbol MSCL during the week of August 9, 2021.

August 6, 2021
·
5 min read
Pharm Country

AIkido Provides Update on Use of Machine Learning in Drug Development Program

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of Medicine.

August 6, 2021
·
4 min read